Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist - PubMed (original) (raw)
Comparative Study
. 2006 Sep;124(1-2):175-83.
doi: 10.1016/j.pain.2006.04.001. Epub 2006 May 18.
Affiliations
- PMID: 16709443
- DOI: 10.1016/j.pain.2006.04.001
Comparative Study
Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist
Fumimasa Amaya et al. Pain. 2006 Sep.
Abstract
Cannabinoids act on various regions in the nervous system to modulate neuronal activity including nociception. Here, we investigated CB1 receptor expression in primary afferent neurons in the dorsal root ganglion (DRG) and the efficacy of a local (intraplantar) application of the selective CB1 agonist, 2-arachidonyl-2-chloroethylamide (ACEA), on inflammatory thermal hyperalgesia. In situ hybridization showed normal CB1 mRNA expression in 28% of DRG neurons. Peripheral inflammation by CFA (complete Freund's adjuvant) significantly increased the ratio of CB1 mRNA-positive neurons to 43%, primarily with increase in NF200-negative C-fiber nociceptors. Furthermore, CB1 and TRPV1 (transient potential receptor vanilloid subtype-1) co-localization was increased from 41% before inflammation to 67% two days after inflammation. Inflammation also increased CB1 immunoreactivity in DRG neurons and in nerve fibers of the hindpaw dermis, indicating increased CB1 transport from the cell body to the peripheral nerve. The intraplantar application of ACEA attenuated CFA-induced thermal hyperalgesia. The antinociceptive properties of ACEA became more prominent at 2 days after inflammation, compared with those in non-inflamed and inflamed animals at 8 h. These results suggest that CB1 expression in primary afferent neurons is increased by inflammation and that the subsequent increase in CB1 transport to peripheral axons contributes to the increased antihyperalgesic efficacy of locally administered CB1 agonist.
Similar articles
- RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat.
Kasama S, Kawakubo M, Suzuki T, Nishizawa T, Ishida A, Nakayama J. Kasama S, et al. Eur J Neurosci. 2007 May;25(10):2956-63. doi: 10.1111/j.1460-9568.2007.05584.x. Epub 2007 May 17. Eur J Neurosci. 2007. PMID: 17509082 - Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J, Heppenstall PA, Mousa SA, Labuz D, Oksche A, Schäfer M, Stein C, Zöllner C. Endres-Becker J, et al. Mol Pharmacol. 2007 Jan;71(1):12-8. doi: 10.1124/mol.106.026740. Epub 2006 Sep 27. Mol Pharmacol. 2007. PMID: 17005903 - Co-expression of the voltage-gated potassium channel Kv1.4 with transient receptor potential channels (TRPV1 and TRPV2) and the cannabinoid receptor CB1 in rat dorsal root ganglion neurons.
Binzen U, Greffrath W, Hennessy S, Bausen M, Saaler-Reinhardt S, Treede RD. Binzen U, et al. Neuroscience. 2006 Oct 13;142(2):527-39. doi: 10.1016/j.neuroscience.2006.06.020. Epub 2006 Aug 4. Neuroscience. 2006. PMID: 16889902 - Role of transient receptor potential A1 in gastric nociception.
Kondo T, Oshima T, Obata K, Sakurai J, Knowles CH, Matsumoto T, Noguchi K, Miwa H. Kondo T, et al. Digestion. 2010;82(3):150-5. doi: 10.1159/000310836. Epub 2010 Jun 25. Digestion. 2010. PMID: 20588026 Review. - Neurogenic aspects of inflammation.
Schaible HG, Del Rosso A, Matucci-Cerinic M. Schaible HG, et al. Rheum Dis Clin North Am. 2005 Feb;31(1):77-101, ix. doi: 10.1016/j.rdc.2004.09.004. Rheum Dis Clin North Am. 2005. PMID: 15639057 Review.
Cited by
- Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation.
Potenzieri C, Brink TS, Pacharinsak C, Simone DA. Potenzieri C, et al. J Neurophysiol. 2008 Nov;100(5):2794-806. doi: 10.1152/jn.90809.2008. Epub 2008 Sep 10. J Neurophysiol. 2008. PMID: 18784270 Free PMC article. - Peripheral gating of pain signals by endogenous lipid mediators.
Piomelli D, Sasso O. Piomelli D, et al. Nat Neurosci. 2014 Feb;17(2):164-74. doi: 10.1038/nn.3612. Epub 2014 Jan 28. Nat Neurosci. 2014. PMID: 24473264 Free PMC article. Review. - The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms.
Potenzieri C, Harding-Rose C, Simone DA. Potenzieri C, et al. Brain Res. 2008 Jun 18;1215:69-75. doi: 10.1016/j.brainres.2008.03.063. Epub 2008 Apr 6. Brain Res. 2008. PMID: 18486111 Free PMC article. - Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants.
Ogawa S, Kunugi H. Ogawa S, et al. Curr Neuropharmacol. 2015;13(6):760-75. doi: 10.2174/1570159x13666150612225212. Curr Neuropharmacol. 2015. PMID: 26630956 Free PMC article. Review. - Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel.
Arnold WR, Carnevale LN, Xie Z, Baylon JL, Tajkhorshid E, Hu H, Das A. Arnold WR, et al. Nat Commun. 2021 Feb 10;12(1):926. doi: 10.1038/s41467-021-20946-6. Nat Commun. 2021. PMID: 33568652 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources